These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23054065)

  • 1. "Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?" Letter to the editor reply.
    Coon EA; Laughlin RS
    J Headache Pain; 2012 Nov; 13(8):687. PubMed ID: 23054065
    [No Abstract]   [Full Text] [Related]  

  • 2. Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?
    Coon EA; Laughlin RS
    J Headache Pain; 2012 Apr; 13(3):255-7. PubMed ID: 22322657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson disease: impulsive choice-Parkinson disease and dopaminergic therapy.
    Voon V; Dalley JW
    Nat Rev Neurol; 2011 Sep; 7(10):541-2. PubMed ID: 21912409
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced burning mouth syndrome: a new clinico-pathological entity?
    Fortuna G; Pollio A
    J Headache Pain; 2012 Nov; 13(8):685-6. PubMed ID: 23054064
    [No Abstract]   [Full Text] [Related]  

  • 5. Fever and rigidity.
    Howard ZD; Rempell JS; Nadel ES; Brown DF
    J Emerg Med; 2011 Jun; 40(6):668-70. PubMed ID: 21074960
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dopamine dysregulation syndrome in a patient with Parkinson's disease; a case report].
    Hol WM; van der Zwaard R; Hovestadt A; van Megen HJ
    Tijdschr Psychiatr; 2010; 52(4):259-63. PubMed ID: 20503167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compulsive use of dopamine replacement therapy in Parkinson's disease: insights into the neurobiology of addiction.
    Brown RM; Lawrence AJ
    Addiction; 2012 Feb; 107(2):250-1. PubMed ID: 22248133
    [No Abstract]   [Full Text] [Related]  

  • 8. Burning mouth disorder and Parkinson's disease: A scoping review of the literature.
    O G; Balasubramaniam R; Klasser GD
    J Oral Rehabil; 2023 Jun; 50(6):488-500. PubMed ID: 36855821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine dysregulation syndrome in non-Parkinson's disease patients: a systematic review.
    Cartoon J; Ramalingam J
    Australas Psychiatry; 2019 Oct; 27(5):456-461. PubMed ID: 31032624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addiction as aberrant learning-evidence from Parkinson's disease.
    Dagher A
    Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132
    [No Abstract]   [Full Text] [Related]  

  • 11. Compulsive use of dopamine replacement therapy among Parkinson's disease patients: if it looks like a duck, swims like a duck and quacks like a duck..
    Kaye S
    Addiction; 2012 Feb; 107(2):251-3. PubMed ID: 22248134
    [No Abstract]   [Full Text] [Related]  

  • 12. Lees' syndrome: a case series.
    Becker N; Munhoz RP; Teive HA
    Arq Neuropsiquiatr; 2011 Oct; 69(5):756-9. PubMed ID: 22042176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current aspects in the therapy of Parkinson's Syndrome].
    Ceballos-Baumann A
    Krankenpfl J; 1991; 29(7-8):310-4. PubMed ID: 1681135
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors influencing dopaminergic therapy of Parkinson's disease.
    Horowski R
    Funct Neurol; 1988; 3(4):459-70. PubMed ID: 2907501
    [No Abstract]   [Full Text] [Related]  

  • 15. Othello syndrome and chronic dopaminergic treatment in patients with Parkinson's disease.
    Kataoka H; Kiriyama T; Eura N; Sawa N; Ueno S
    Parkinsonism Relat Disord; 2014 Mar; 20(3):337-9. PubMed ID: 24054315
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in Parkinson's disease.
    Vécsei L
    Ideggyogy Sz; 2002 Nov; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract]   [Full Text] [Related]  

  • 17. Low frequency of bipolar disorder, dopamine dysregulation syndrome, and punding in Brazilian patients with Parkinson's disease.
    Kummer A; Dias FM; Cardoso F; Teixeira AL
    Braz J Psychiatry; 2010 Mar; 32(1):62-5. PubMed ID: 20339736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection for Parkinson's disease.
    Koller WC
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S155-9. PubMed ID: 9749588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 20. Restlessness restricted to the perianal region in a patient with Parkinson's disease.
    Okamura M; Suzuki K; Matsubara T; Hirata K
    Parkinsonism Relat Disord; 2018 Jun; 51():117-118. PubMed ID: 29506822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.